Toxicity of sucralose in humans: A review;Toxicidad de la sucralosa en humanos: Una revisión

International Journal of Morphology

Volumn 27, Issue 1, 2009, Pages 239-244

  Rodero, Ademir Barianni ^a   Rodero, Lucas de Souza ^b   Azoubel, Reinaldo ^c  

^a UNIVERSIDADE CAMILO CASTELO BRANCO   (Brazil)

^b Primate Center   (Brazil)

^c Institute of Biomedicine   (Brazil)

Author keywords

Sucralose; Sweetener; Toxicology

Indexed keywords

EID: 68249135450     PISSN: 07179367     EISSN: 07179502     Source Type: Journal    
DOI: 10.4067/S0717-95022009000100040     Document Type: Article

References (33)

1. Arruda, J. G. F.; Martins, A. T. & Azoubel, R. Ciclamato de sódio e rim fetal. Rev. Bras. Saúde Matern. Infant., 3(2):147-50, 2003.
2. Barndt, R. L. & Jackson, G. Stability of sucralose in baked goods. Food Technol., 44(1):62-6,1990.
3. Binns, N. M. Sucralose: Alt sweeteners and light. Nutr. Bull. BNF., 29(1):53-8, 2003.
4. Campos, M. B. Aplicação de sucralose em iogurtes e prepa-rados de frutas para iogurtes. Food Ingredients,19:68-71, 2002.
5. Campos, M. B. Sucralose: a revolução em adoçantes. Food Ingredients, 17:18-21, 2000.
6. Candido, L. M. B. & Campos, A. M. Alimentos para fins especiais: dietéticos. São Paulo, Livraria Varela, 1995. p.423
7. De Matos, M. A.; Martins, A. T. & Azoubel, R. Efectos del ciclamato de sodio en la placenta de rata: estudio morfométrico. Int. J. Morphol., 24(2):137-42, 2006.
8. Department of Health and Human Services. Food and Drug Administration. Food additives permitted for direct addition to food for human consumption; Sucralose. 21 CFR Part 172 [Docket no 99F-0001]. Federal Register, 64(155):43908, 1999.
9. Finn, J. P. & Lord, G. H. Neurotoxicity studies on sucralose and its hydrolysis products with special reference to histopathologic and ultrastructural changes. Food Chem. Toxicol., 38(2): S7-17, 2000.
10. Frank, G. Sucralose: An overview. Undergraduate Res. J. Hum. Sciences (URC), 1:1-13, 2002.
11. Goldsmith, L. A. & Meckel, C. M. Sucralose. In: Nabors, L. O'B. & Gelardi, R. C. Edit. Alternative sweeteners. 3.ed. New York, Marcel Dekker, 2001. pp.185-207.
12. Grice, H. C. & Goldsmith, L. A. Sucralose: an overview of the toxicity data. Food Chem. Toxicol., 38(2):S1-6, 2000.
13. Houghes, H. M.; Powell, G. M.; Snodin, D. J.; Daniel, J. W.; Crawford, A.; Sanders, J. K. & Curtis, C. G. Glutathione-dependent dechlorination of 1,6-dichloro-1,6- dideoxyfructose. Biochem. J., 259(2):537-43, 1989.
14. John, B. A.; Wood, S. G. & Hawkins, D. R. The pharmacokinetics and metabolism of sucralose in the rabbit. Food Chem. Toxicol., 38(2):S111-3, 2000.
15. Kille, J. W.; Tesh, J. M.; McAnulty, P. A.; Ross, F. W.; Willoughby, C. R.; Bailey, G. P.; Wilby, O. K. & Tesh, S. A. Sucralose: Assessment of teratogenic potential in the rat and rabbit. Food Chem. Toxicol., 38(2):S43-52, 2000.
16. Knight I. The development and applications of sucralose, a new high-intensity sweetener. Can. J. Physiol. Pharmacol., 72(4):435-9, 1994.
17. Lopes, H. F. & Drager, L. F. Doenças cardiovasculares: obesidade e síndrome metabólica. In: Lopes, A. C. Edit. Tratado de clínica médica. São Paulo, Roca, 2006. pp.712-27.
18. Lord, G. H. & Newberne, P. M. Renal mineralization: A ubiquitous lesions in chronic rat studies. Food Chem. Toxicol., 28(8):449-55, 1990.
19. Mandel, L. D. & Grotz, V. L. Dental considerations in sucralose use. J. Clin. Dent., 13(3):116-8, 2002.
20. Mann, S. W.; Yuschak, M. M.; Amyes, S. J.; Aughton, P. & Finn, J. P. A combined chronic toxicity/carcinogenicity study of sucralose in Sprague-Dawley rats. Food Chem. Toxicol., 38(2):S71-89, 2000.
21. Martins, A. T.; Azoubel, R.; Lopes, R. A.; Di Matteo, M. A. S. & Arruda, J. G. F. Efectos del ciclamato de sódio en el hígado fetal de ratas: Estudios cariométrico y estereológico. Int J Morphol., 23(3):221-6, 2005.
22. McNeil Nutritionals. Splenda® Brand Sweetener: A guide for healthcare professionals. Washington, McNeil Nutritionals, 2006.
23. McNeil Specialty Products. Food Additive Petition 7A3987: Sucralose. Washington, McNeil Specialty Products, 1987.
24. Ono, T.; Guthold, R. & Strong, K. WHO Global comparable estimates. Genebra, WHO, 2005.
25. Ophardt, C. E. Virtual Chembook, Department of Chemistry, Elmhurst, IL., Elmhurst College, 2003.
26. Pachione, R. Indústria do diet engorda as vendas. Rev. Quím. Derivados., 419(1):38-50, 2003.
27. Portela, G. S. & Azoubel, R. Nefrotoxicidade fetal com o uso da amicacina. Estudo cariométrico. J. Bras. Nefrol., 26(1):12-8, 2004.
28. Portela, G. S.; Azoubel, R. & Batigália, F. Effects of aspartame on maternal-fetal and placental weights, lenght of umbilical cord and fetal liver: a kariometric experi-mental study. Int. J. Morphol., 25(3):549-54, 2007.
29. Roberts, A.; Renwick, A. G., Sims, J. & Snodin, D. J. Sucralose metabolism and pharmacokinetics in man. Food Chem. Toxicol., 38(2):S31-41, 2000.
30. Sham, W. S. Splenda: A safe and sweet alternative to sugar. Nutr. Bites., 10(2):1-5, 2005.
31. Sims, J.; Roberts, A.; Daniel, J. W. & Renwick, A. G. The metabolic fate of sucralose in rats. Food Chem. Toxicol., 38(2):S115-21, 2000.
32. Whitmore, A. FDA approves new high-intensity sweeteners sucralose. FDA Talk, 16, 1998.
33. Wood, S. G.; John, B. A. & Hawkins, D. R. The pharmacokinetics and metabolism of sucralose in the dog. Food Chem. Toxicol., 38(Suppl 2):S99-106, 2000.